{"id":"https://openalex.org/W4406992568","doi":"https://doi.org/10.1161/str.56.suppl_1.89","title":"Abstract 89: A first-in-class humanized antibody fragment targeting platelet glycoprotein Ib\u03b1: a comprehensive preclinical study of CA1001 for the treatment of acute ischemic stroke","display_name":"Abstract 89: A first-in-class humanized antibody fragment targeting platelet glycoprotein Ib\u03b1: a comprehensive preclinical study of CA1001 for the treatment of acute ischemic stroke","publication_year":2025,"publication_date":"2025-01-30","ids":{"openalex":"https://openalex.org/W4406992568","doi":"https://doi.org/10.1161/str.56.suppl_1.89"},"language":"en","primary_location":{"id":"doi:10.1161/str.56.suppl_1.89","doi":"https://doi.org/10.1161/str.56.suppl_1.89","is_oa":false,"landing_page_url":"https://doi.org/10.1161/str.56.suppl_1.89","pdf_url":null,"source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112678721","display_name":"Xiaohong Xu","orcid":"https://orcid.org/0009-0007-2370-1714","observed_orcids":["https://orcid.org/0009-0007-2370-1714"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaohong Xu","raw_affiliation_strings":["CCOA Therapeutics Inc, T, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCOA Therapeutics Inc, T, Ontario, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xi Lei","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xi Lei","raw_affiliation_strings":["CCOA Therapeutics Inc, T, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCOA Therapeutics Inc, T, Ontario, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057695451","display_name":"Guangheng Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297363086","display_name":"St. Michael's Hospital","ror":"https://ror.org/04skqfp25","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Guangheng Zhu","raw_affiliation_strings":["St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1297363086","https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Zhenze Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhenze Liu","raw_affiliation_strings":["CCOA Therapeutics Inc, T, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCOA Therapeutics Inc, T, Ontario, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xudong Hu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xudong Hu","raw_affiliation_strings":["CCOA Therapeutics Inc, T, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCOA Therapeutics Inc, T, Ontario, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013519490","display_name":"Sladjana Slavkovic","orcid":"https://orcid.org/0000-0002-6927-1154","observed_orcids":["https://orcid.org/0000-0002-6927-1154"]},"institutions":[{"id":"https://openalex.org/I95297979","display_name":"Canadian Blood Services","ror":"https://ror.org/01jays723","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I95297979"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sladjana Slavkovic","raw_affiliation_strings":["Canadian Blood Services Centre for Innovation, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Canadian Blood Services Centre for Innovation, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I95297979"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075084336","display_name":"Miguel A. D. Neves","orcid":"https://orcid.org/0000-0002-2220-486X","observed_orcids":["https://orcid.org/0000-0002-2220-486X"]},"institutions":[{"id":"https://openalex.org/I95297979","display_name":"Canadian Blood Services","ror":"https://ror.org/01jays723","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I95297979"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Miguel Neves","raw_affiliation_strings":["Canadian Blood Services Centre for Innovation, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Canadian Blood Services Centre for Innovation, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I95297979"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Wenjing Ma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297363086","display_name":"St. Michael's Hospital","ror":"https://ror.org/04skqfp25","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Wenjing Ma","raw_affiliation_strings":["St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1297363086","https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101318441","display_name":"Huifang Xie","orcid":"https://orcid.org/0009-0008-7168-1241","observed_orcids":["https://orcid.org/0009-0008-7168-1241"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huifang Xie","raw_affiliation_strings":["CCOA Therapeutics (Hangzhou) Co., Ltd., Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCOA Therapeutics (Hangzhou) Co., Ltd., Hangzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Preeti Preeti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297363086","display_name":"St. Michael's Hospital","ror":"https://ror.org/04skqfp25","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Preeti Preeti","raw_affiliation_strings":["St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1297363086","https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017330670","display_name":"Ruoying Yu","orcid":"https://orcid.org/0000-0003-1560-239X","observed_orcids":["https://orcid.org/0000-0003-1560-239X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruoying Yu","raw_affiliation_strings":["CCOA Therapeutics Inc, T, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCOA Therapeutics Inc, T, Ontario, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005312839","display_name":"Hamed Shaykhalishahi","orcid":"https://orcid.org/0000-0002-4632-4858","observed_orcids":["https://orcid.org/0000-0002-4632-4858"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hamed Shaykhalishahi","raw_affiliation_strings":["CCOA Therapeutics Inc, T, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCOA Therapeutics Inc, T, Ontario, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100439707","display_name":"Cheng Zhang","orcid":"https://orcid.org/0000-0003-3843-1562","observed_orcids":["https://orcid.org/0000-0003-3843-1562","https://orcid.org/0009-0002-0240-4845"]},"institutions":[{"id":"https://openalex.org/I1297363086","display_name":"St. Michael's Hospital","ror":"https://ror.org/04skqfp25","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Cheng Zhang","raw_affiliation_strings":["St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1297363086","https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071342749","display_name":"Chuanbin Shen","orcid":"https://orcid.org/0000-0002-4635-5160","observed_orcids":["https://orcid.org/0000-0002-4635-5160"]},"institutions":[{"id":"https://openalex.org/I1297363086","display_name":"St. Michael's Hospital","ror":"https://ror.org/04skqfp25","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Chuanbin Shen","raw_affiliation_strings":["St Michael's Hospital, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St Michael's Hospital, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1297363086"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Bei Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bei Li","raw_affiliation_strings":["CCOA Therapeutics (Hangzhou) Co., Ltd., Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCOA Therapeutics (Hangzhou) Co., Ltd., Hangzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032434175","display_name":"Naping Tang","orcid":"https://orcid.org/0000-0002-0807-2354","observed_orcids":["https://orcid.org/0000-0002-0807-2354"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naping Tang","raw_affiliation_strings":["Shanghai InnoStar Bio-tech Co., Ltd., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai InnoStar Bio-tech Co., Ltd., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100714644","display_name":"Yan Chang","orcid":"https://orcid.org/0000-0001-5846-8819","observed_orcids":["https://orcid.org/0000-0001-5846-8819"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Chang","raw_affiliation_strings":["Shanghai InnoStar Bio-tech Co., Ltd., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai InnoStar Bio-tech Co., Ltd., Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062487012","display_name":"Qian Xiang","orcid":"https://orcid.org/0000-0002-8245-2611","observed_orcids":["https://orcid.org/0000-0002-8245-2611"]},"institutions":[{"id":"https://openalex.org/I4210130930","display_name":"Peking University First Hospital","ror":"https://ror.org/02z1vqm45","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210130930"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qian Xiang","raw_affiliation_strings":["Peking University First Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peking University First Hospital, Beijing, China","institution_ids":["https://openalex.org/I4210130930"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yimin Cui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130930","display_name":"Peking University First Hospital","ror":"https://ror.org/02z1vqm45","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210130930"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yimin Cui","raw_affiliation_strings":["Peking University First Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peking University First Hospital, Beijing, China","institution_ids":["https://openalex.org/I4210130930"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050268815","display_name":"Heyu Ni","orcid":"https://orcid.org/0000-0002-7621-2945","observed_orcids":["https://orcid.org/0000-0002-7621-2945"]},"institutions":[{"id":"https://openalex.org/I1297363086","display_name":"St. Michael's Hospital","ror":"https://ror.org/04skqfp25","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Heyu Ni","raw_affiliation_strings":["St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1297363086","https://openalex.org/I185261750"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"56","issue":"Suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/platelet-glycoprotein-ibalpha","display_name":"platelet glycoprotein Ib\u03b1","score":0.8999999761581421},{"id":"https://openalex.org/keywords/acute-ischemic-stroke","display_name":"acute ischemic stroke","score":0.9750000238418579},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.8960000276565552},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.5950000286102295},{"id":"https://openalex.org/keywords/intravital-microscopy","display_name":"intravital microscopy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/transient-middle-cerebral-artery-occlusion","display_name":"transient middle cerebral artery occlusion","score":0.9810000061988831},{"id":"https://openalex.org/keywords/ristocetin-induced-platelet-aggregation","display_name":"ristocetin-induced platelet aggregation","score":0.9139999747276306},{"id":"https://openalex.org/keywords/thrombus-dissolution","display_name":"thrombus dissolution","score":0.828000009059906},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7419999837875366},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9490000009536743},{"id":"https://openalex.org/keywords/toxicology","display_name":"toxicology","score":0.7540000081062317},{"id":"https://openalex.org/keywords/cerebral-infarct-volume","display_name":"cerebral infarct volume","score":0.7710000276565552},{"id":"https://openalex.org/keywords/intracerebral-hemorrhage","display_name":"intracerebral hemorrhage","score":0.7960000038146973}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9805300235748291},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5562397241592407},{"id":"https://openalex.org/C3020199598","wikidata":"https://www.wikidata.org/wiki/Q12202","display_name":"Ischemic stroke","level":3,"score":0.5463195443153381},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.5382627248764038},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5378431677818298},{"id":"https://openalex.org/C26828662","wikidata":"https://www.wikidata.org/wiki/Q7202248","display_name":"Platelet membrane glycoprotein","level":3,"score":0.4875278174877167},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.432758092880249},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.413443386554718},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3869331181049347},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.22145164012908936},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19848063588142395},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/str.56.suppl_1.89","doi":"https://doi.org/10.1161/str.56.suppl_1.89","is_oa":false,"landing_page_url":"https://doi.org/10.1161/str.56.suppl_1.89","pdf_url":null,"source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2579011077","https://openalex.org/W1972429479","https://openalex.org/W4401672250","https://openalex.org/W2119668201","https://openalex.org/W4407260973","https://openalex.org/W4248372250","https://openalex.org/W2173549606","https://openalex.org/W4296711038","https://openalex.org/W6929871512","https://openalex.org/W1976425448"],"abstract_inverted_index":{"Introduction:":[0],"Platelet":[1],"glycoprotein":[2],"(GP)":[3],"Ib\u03b1":[4],"is":[5,27],"a":[6,43,116,190],"key":[7],"receptor":[8],"for":[9,19,32,49],"thrombosis.":[10],"Under":[11],"high":[12],"shear":[13],"conditions,":[14],"GPIb\u03b1-VWF":[15],"interactions":[16],"are":[17,295],"required":[18],"initiating":[20],"platelet":[21,88,132,159,276],"adhesion":[22],"and":[23,70,94,103,115,125,140,149,167,180,249,271,287,291,297,318,321,331],"vessel":[24,178],"occlusion.":[25],"GPIb\u03b1":[26,133],"also":[28],"an":[29],"important":[30],"checkpoint":[31],"thrombo-inflammation":[33],"in":[34,86,95,123,161,186,236,239,285,328],"acute":[35,334],"ischemic":[36,47,335],"stroke.":[37,336],"It":[38],"has":[39,55,311],"been":[40,56],"considered":[41],"as":[42],"desirable":[44],"target":[45],"against":[46],"stroke":[48],"decades,":[50],"but":[51],"no":[52],"anti-GPIb\u03b1":[53,308],"drug":[54],"successfully":[57],"developed.":[58],"Methods:":[59],"CA1001":[60,81,129,155,174,197,227,267,310],"was":[61,82,242,268],"humanized":[62,307],"from":[63,134,144],"our":[64],"unique":[65],"mAb":[66],"crossing":[67],"different":[68],"species,":[69],"manufactured":[71],"under":[72],"GMP-like":[73],"conditions":[74],"with":[75,91,151,260,333],"99.9%":[76],"purity.":[77],"The":[78,218,247,279,305],"efficacy":[79],"of":[80,196,215,226,251],"assessed":[83],"using":[84],"various":[85],"vitro":[87,162],"functional":[89],"assays":[90],"blood":[92],"samples":[93],"vivo":[96,187],"models,":[97,173,193],"including":[98],"state-of-the-art":[99],"intravital":[100,171],"microscopy":[101,172],"thrombosis":[102],"transient":[104],"middle":[105],"cerebral":[106,205],"artery":[107,153],"occlusion":[108],"(tMCAO)":[109],"models.":[110],"Pharmacokinetics":[111],"(PK),":[112],"pharmacodynamics":[113],"(PD),":[114],"14-day":[117],"regulatory":[118],"toxicology":[119,265],"study":[120],"were":[121,254,289],"conducted":[122],"rats":[124,286],"rhesus":[126,145],"monkeys.":[127],"Results:":[128],"specifically":[130],"recognized":[131],"human,":[135],"monkeys,":[136,146],"rats,":[137,237],"mice,":[138],"rabbits":[139],"dogs.":[141],"Using":[142,164],"platelets":[143],"healthy":[147,329],"volunteers,":[148],"patients":[150,332],"peripheral":[152],"disease,":[154],"dose-dependently":[156],"inhibited":[157,175],"ristocetin-induced":[158],"aggregation":[160],".":[163,188],"laser":[165],"injury":[166,170],"FeCl":[168],"3":[169],"thrombosis,":[176],"prevented":[177],"occlusion,":[179],"importantly,":[181],"promoted":[182],"thrombus":[183],"dissolution":[184],"(thrombolysis)":[185],"In":[189,264],"60-min":[191],"tMCAO":[192,201],"intravenous":[194,245],"injection":[195,225],"1":[198],"hour":[199],"after":[200],"significantly":[202],"reduced":[203],"the":[204,213,252,261,300],"infarct":[206],"volume":[207],"at":[208],"24":[209],"hours":[210],"without":[211,273],"increasing":[212],"risk":[214],"intracerebral":[216],"hemorrhage.":[217],"PD":[219],"studies":[220],"showed":[221],"that":[222],"single":[223],"bolus":[224],"reached":[228],"maximal":[229],"anti-platelet":[230],"effects":[231],"within":[232],"5":[233],"minutes":[234],"(0.25mg/kg":[235],"4mg/kg":[238],"monkeys)":[240],"which":[241,294],"maintained":[243],"following":[244],"infusion.":[246],"extent":[248],"duration":[250],"effect":[253],"dose-dependent.":[255],"Plasma":[256],"concentrations":[257],"increased":[258],"linearly":[259],"dose":[262],"received.":[263],"studies,":[266],"well":[269],"tolerated":[270],"safe":[272],"bleeding":[274],"nor":[275],"count":[277],"reduction.":[278],"No":[280],"Obvious":[281],"Adverse":[282],"Event":[283],"Level":[284],"monkeys":[288],"25mg/kg,":[290],"100mg/kg":[292],"respectively,":[293],"10":[296],"25":[298],"times":[299],"therapeutic":[301],"targeted":[302],"doses.":[303],"Conclusion:":[304],"first-in-class":[306],"Fab":[309],"potent":[312],"anti-thrombotic":[313],"effects,":[314],"consistent":[315],"PK/PD":[316],"properties":[317],"favorable":[319],"safety":[320],"tolerability":[322],"profiles":[323],"warranting":[324],"further":[325],"clinical":[326],"development":[327],"volunteers":[330]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-01-31T00:00:00"}